CRF Health Selected to Support One of the Largest Recorded COPD Trials Involving 19,000+ Patients

April 14, 2016 Dana Perotti


Plymouth Meeting, PA – April 14, 2016: CRF Health, the leading global provider of eCOA solutions for the life sciences industry, announces that its TrialMax® platform has been adopted by a leading developer of therapeutics for respiratory disease conditions to support one of the largest recorded Phase III studies into chronic obstructive pulmonary disease (COPD). The trial, involving more than 19,000 patients, will use the TrialMax platform to deliver electronic versions of key COPD instruments, enabling investigators to monitor exacerbations, while making compliance as easy as possible for patients.

COPD trials routinely face reduced compliance due to a patient population which must regularly complete patient reported outcomes while struggling with lowered energy levels. In this large scale global study, which will involve more than 900 clinical research sites in nearly 40 countries, the TrialMax solution will make data collection as efficient and unobtrusive as possible, driving the collection of a more complete data set through increased compliance.

"Our TrialMax platform is designed to fit into patients' real lives to fuel high compliance, making it the ideal solution to overcome the adherence challenges that are prevalent in COPD trials, especially in a patient population of this size", said John Blakeley, Chief Business Officer at CRF Health. "We're delighted to be part of one of the largest recorded clinical studies of COPD and supporting research advancements that will result in better treatments for those living with the challenges associated with the condition."

For further information on CRF Health, please visit

About CRF Health

CRF Health is the leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials.  With experience in more than 800 trials, over 100 languages and across 74 countries, CRF Health’s TrialMax eCOA solutions consistently demonstrate the industry’s highest data accuracy, patient and site compliance, and patient retention.

CRF Health’s TrialMax eCOA solutions improve trial engagement by fitting into the lives of patients and seamlessly integrating into sites to maximize protocol compliance.  Their eCOA solutions include PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes) and ClinROs (Clinician or Rater Reported Outcomes).

Contact:, +1 267.498.2350

 CRF Health Launches TrialConsent™, a TrialMax® Platform Extension
CRF Health Launches TrialConsent™, a TrialMax® Platform Extension

CRF Health Named Clinical & Research Excellence Awards Finalist for Best Patient-Focused Technology